By Frank Prenesti
Date: Friday 01 Jul 2022
(Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
Total Voting Rights | 01-Jul-2022 | 17:50 | RNS |
Director/PDMR Shareholding | 01-Jul-2022 | 17:43 | RNS |
Form 8.3 -Ultra Electronics Holdings plc Amendment | 01-Jul-2022 | 16:54 | RNS |
Form 8.3 - Meggitt plc Amendment | 01-Jul-2022 | 16:35 | RNS |
Form 8.5 (EPT/RI)-Replacement of Ultra Electronics | 01-Jul-2022 | 16:14 | RNS |
Questor:Meggitt | 23-Dec-2014 | Telegraph |
Questor :Ricardo | 31-Oct-2014 | Telegraph |
Questor:CSR | 17-Oct-2014 | Telegraph |
Questor:BAE Systems | 03-Sep-2014 | Telegraph |
Questor :Sage Group | 09-May-2014 | Telegraph |
Price | 5,775.58 |
Change Today | 29.28 |
% Change | 0.51 % |
01-Jul-22 Close | 5,775.58 |
You are here: research